For Research Use Only · Not for human or veterinary consumption
Tirzepatide 60 mg
Hover to zoom
Research PeptideResearch Use Only

Tirzepatide 60 mg

60 mg lyophilized

Tirzepatide is a dual GIP and GLP-1 receptor agonist research peptide studied in incretin pathway research, endocrine research, metabolic signaling models, and receptor activity studies.

$130.00
Per unit · Research material
1
Total: $130.00
View Inquiry Cart

No dosing, administration, or human-use guidance is provided. Submissions are reviewed for qualified research use.

Overview

Product Overview

Tirzepatide is a dual GIP and GLP-1 receptor agonist research peptide studied in incretin pathway research, endocrine research, metabolic signaling models, and receptor activity studies.

Package

Package Information

Product
Tirzepatide 60 mg
Form
Lyophilized Powder
Purity
≥ 98%
Storage
Store at 2–8°C
Category
Research Peptide
Price
$130.00
Specifications

Compound Facts

Compound type
Peptide research material
Primary pathway
GIP and GLP-1 receptors
Research category
Incretin and metabolic research
Form
Lyophilized
Intended use
Laboratory research only
Human or veterinary use
Not permitted
Context

Research Information

Neutral, research-context information on the pathways and laboratory work involving this compound. None of the content below describes human use, dosing, or medical application.

  • Studied as a dual agonist of the GIP and GLP-1 receptors.
  • Investigated in metabolic and energy-regulation research models.
  • Used in receptor-pharmacology and signaling research workflows.
  • Not a medicine. Not approved for human use.
Dual receptor pharmacology

Research investigates simultaneous activation of GIP and GLP-1 receptors and the resulting cAMP and beta-arrestin signaling profiles in receptor pharmacology models.

Incretin pathway research

Studied in models exploring the incretin axis, including in vitro pancreatic beta-cell systems researching insulin-secretion signaling.

Comparative agonist studies

Used alongside selective GLP-1 reference agonists to compare receptor activation patterns, ligand bias, and signaling kinetics in laboratory research.

About

Product Overview

Tirzepatide 60 mg is supplied by Blue Peak Health as a lyophilized research peptide for incretin pathway, dual-receptor pharmacology, and metabolic signaling research. It is frequently selected for studies that characterize simultaneous activation of GIP and GLP-1 receptors and the resulting signaling profiles. Every shipment is batch-tracked and documented for analytical workflows.

Applications

Research Applications

Dual receptor pharmacology

Used in cell-based assays investigating simultaneous GIP and GLP-1 receptor activation and resulting cAMP / beta-arrestin signaling profiles.

Incretin pathway research

Applied in pancreatic beta-cell and ex-vivo models exploring incretin axis biology and insulin-secretion signaling.

Comparative agonist studies

Studied alongside selective GLP-1 reference peptides to compare ligand bias and signaling kinetics.

Compound

Compound Information

Tirzepatide is a dual GIP and GLP-1 receptor agonist peptide supplied lyophilized for reconstitution in qualified laboratory environments. It is widely cited as a benchmark dual-agonist reference material in metabolic and endocrine research literature.

Further pathway context is available on our research facts page.

Handling

Storage & Handling

  • Store in a controlled laboratory environment per accepted protocols for the compound class.
  • Protect from direct light, heat, and ambient moisture during storage and handling.
  • Reseal containers immediately after sampling to preserve batch integrity.
  • Handle only in qualified research environments using appropriate PPE.
  • Follow institutional chemical hygiene and biosafety guidelines at all times.
  • Not intended for injection, ingestion, topical use, or use in humans or animals.
Quality

Quality Standards

  • Purity target of 98% or higher across reference batches.
  • Unique batch identifier supplied with every shipment for full traceability.
  • Certificate of Analysis available on request for qualified researchers.
  • Characterized with standard analytical methods appropriate to the compound class.
  • Labeled and supplied strictly as a research material — never as a medicine, supplement, food, or cosmetic.

Full quality standards apply to every batch.

FAQ

Frequently Asked Questions

Is this material intended for human or veterinary use?+

No. All Blue Peak Health materials are supplied strictly for laboratory research use only and are not intended for human or veterinary consumption, administration, or application of any kind.

Is documentation available for each batch?+

Yes. Each shipment carries a unique batch identifier, and a Certificate of Analysis can be requested by qualified researchers to support analytical and laboratory workflows.

Who is permitted to purchase research materials?+

Only qualified researchers, laboratories, and institutions purchasing for lawful in-vitro research and analytical work. Submissions are reviewed before fulfilment.

Are dosing or administration instructions provided?+

No. Blue Peak Health does not provide dosing, administration, injection, ingestion, or human-use instructions of any kind. Materials are supplied for the bench only.

More questions answered in our full FAQ.

Research Disclaimer

This product is supplied strictly as a research material and is not intended for medical, dietary, cosmetic, or veterinary use.

For research use only. Not for human or veterinary consumption. Not a drug, food, dietary supplement, or cosmetic. Not intended to diagnose, treat, cure, or prevent any disease.

Next Step

Inquire about Tirzepatide 60 mg

Submit a research inquiry to request details, certificate of analysis, and availability. Reviewed for qualified researchers and laboratories only.

Related research materials